537MO First-in-human study of JNJ-64619178, a protein arginine methyltransferase 5 (PRMT5) inhibitor, in patients with advanced cancersM. Vieito Villar,A. Spreafico,V. Moreno,I. Braña,T. Hernandez,A. Abdul Razak,J. Wang, N. Haddish-Berhane, J. Mehta,A. Johnson,A. Maes, J. Haslam, P. Mistry, A. Kalota, L. Lenox,J. Infante,M. Lorenzi,H. Xie, J. Lauring,M.R. PatelAnnals of Oncology（2020）引用 12|浏览64暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
